Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gastrointestinal tumors
Biotech
Cancer biotech Inspirna winding down
Inspirna is closing down as the sun sets on its mircoRNA platform work.
Ben Adams
Apr 1, 2025 3:50am
ArriVent pays Lepu $47M for GI-focused preclinical ADC
Jan 22, 2025 7:15am
JPM25: M&A strategist GSK acquires IDRx for $1B upfront
Jan 13, 2025 2:00am
GSK goes East again, snagging option on DualityBio ADC for $30M
Dec 4, 2024 8:20am
Daily aspirin use may limit spread of colorectal tumor cells
Apr 23, 2024 3:50am
Gilead stops phase 3 TIGIT trial, doubles down on other studies
Jan 30, 2024 8:09am
